TickerFactsScreenerDevelopers

Pacira BioSciences, Inc. (PCRX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $5.51M2010: $6.77M2011: $6.17M2012: $18.26M2013: $12.17M2014: $22.98M2015: $40.30M2016: $24.71M2017: $19.27M2018: $14.51M2019: $10.16M2020: $37.80M2021: $45.87M2022: $30.08M2023: $15.16M2024: $10.64M2025: $15.33M$15.33M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$15.33M+44.2%
2024$10.64M-29.8%
2023$15.16M-49.6%
2022$30.08M-34.4%
2021$45.87M+21.3%
2020$37.80M+272.1%
2019$10.16M-30.0%
2018$14.51M-24.7%
2017$19.27M-22.0%
2016$24.71M-38.7%
2015$40.30M+75.3%
2014$22.98M+88.8%
2013$12.17M-33.3%
2012$18.26M+196.0%
2011$6.17M-8.9%
2010$6.77M+22.9%
2009$5.51M—